Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for reducing intraoperative blood loss during open posterior spine surgery in West African adults
PACTR202508855342037Phase 3Completed
- Sponsor
- Simon Balogun
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Back disorder (2 arms), sponsored by Simon Balogun. Primary endpoint: Intraoperative blood loss. Started Apr 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Back disorder
Beyond the preview
Go deeper on PACTR202508855342037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508855342037.